Zahra Ghasemi: The Human Reality of IVIG Access
Zahra Ghasemi, Pharmacoeconomist, Member of Health Technology Assessment international and Cochrane, shared a post on LinkedIn:
“Different diagnoses, one lifeline: The human reality of IVIG access!
Last year, I shared a deeply personal chapter of my life: my sister’s battle with Guillain-Barré Syndrome (GBS).
While that experience was a sudden, acute crisis, today marks the start of Primary Immunodeficiency Diseases International Awareness Week.
On the surface, these conditions seem worlds apart; one is a rare neurological attack, the other a lifelong immune deficiency, but they are bound together by a single, critical lifeline: IVIG.
Today, a global effort is shining a light on primary immunodeficiency, a group of over 400 rare, chronic disorders in which the body’s immune system is missing or functions improperly.
For millions of PID patients, IVIG is not just ‘medication’; it is their external immune system.
It is the bridge that allows a child to go to school or an adult to sustain a career.
Yet, because these therapies rely entirely on human plasma donation and complex fractionation, ‘access’ remains one of our greatest global health challenges.
Awareness is the first step toward policy change.
Whether we are industry professionals, policymakers, or citizens, we must advocate for a world in which ‘plasma, the liquid gold’ is accessible to every patient who relies on it to survive.”
Stay updated with Hemostasis Today.
-
Nov 12, 2026, 10:30Nancy Di Salvo: Protecting Access to IVIG and SCIG – A Call for Continued EU Recognition
-
Nov 12, 2026, 10:28Ali Hammed: Should DOAC Use Exclude Patients From Thrombolysis After Ischemic Stroke?
-
Nov 12, 2026, 10:21Aseem Kumar Tiwari: The Molecular Dimension of HLA Matching
-
Nov 12, 2026, 10:18Sarah Connolly: Developing Advanced Haematology Services in Cancer Care
-
Nov 12, 2026, 10:13Carlos Esteban Gasko: Restrictive Transfusion in Critical Care
-
Nov 12, 2026, 10:07Samin Mohsenian: Advancing Care in Rare Bleeding Disorders
-
Nov 12, 2026, 10:03Influenza Vaccination in Patients With ITP – ITP Support Association
-
Nov 12, 2026, 10:00Akshat Jain: Asundexian for Recurrent Stroke Prevention
-
Nov 12, 2026, 09:57Romy Meier: From Research to New Scientific Perspectives on HIT and VITT